Mark V. Sauer Author
Subjects of specialization
Andrology, Gynecology
Editorial Open Access
Author(s): Mark V. Sauer
A Missed Opportunity: FDA and Mitochondrial Manipulation Technology
On February 25th and 26th2014 the Federal Drug Administration(FDA) convened a Cellular, Tissue and Gene Advisory Committee meeting in Gaithersburg, Maryland. The stated purpose of this meeting was to review basic and clinical research related to “Oocyte modification in Assisted Reproduction for the Prevention of Mitochondrial Disease or Treatment of Infertility”, in order to make recommendations regarding the proper conduct... view moreĀ»